Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome

References

• Keeffe EB. Future treatment of chronic hepatitis C. Antivir Ther 2007; 12: 1015–25
   PubMedGoogle Scholar
• Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35–46
   PubMed Web of Science ®Google Scholar
• Colombo M. Hepatitis C virus and hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 519–28
   PubMedGoogle Scholar
• Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. J Gastrointest Liver Dis 2007; 16: 65–73
   PubMed Web of Science ®Google Scholar
• Cacoub, P, Renou, C, Rosenthal, E, Cohen, P, Loury, I, Loustaud-Ratti, V, , et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore), 2000;79:47–56.
   Google Scholar
• Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum 1999; 42: 2204–12
   PubMed Web of Science ®Google Scholar
• Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999; 31 Suppl 1: 39–42
   PubMedGoogle Scholar
• Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 1999; 31: 369–76
   PubMed Web of Science ®Google Scholar
• Matsumori A. Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus. Intern Med 2001; 40: 182–4
   PubMedGoogle Scholar
• Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321–3
   PubMed Web of Science ®Google Scholar
• Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Dis 2008; 14: 123–30
   PubMed Web of Science ®Google Scholar
• Madrid C, Courtois B, Duran D. Chronic sialadenitis revealing hepatitis C: a case report. Med Oral 2004; 9: 328–32
   PubMedGoogle Scholar
• Toussirot E, Le Huede G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection. J Rheumatol 2002; 29: 2382–5
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, et al. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005; 84: 81–9
   PubMed Web of Science ®Google Scholar
• Delaleu N, Jonsson R, Koller MM. Sjögren's syndrome. Eur J Oral Sci 2005; 113: 101–13
   PubMed Web of Science ®Google Scholar
• Delaleu N, Immervoll H, Cornelius J, Jonsson R. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 2008; 10: R22
   PubMed Web of Science ®Google Scholar
• Jonsson R, Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome. Scand J Rheumatol 2000; 29: 341–8
   PubMed Web of Science ®Google Scholar
• Jonsson R, Bolstad AI, Brokstad KA, Brun JG. Sjögren's syndrome: a plethora of clinical and immunological phenotypes with a complex genetic background. Ann NY Acad Sci 2007; 1108: 433–47
   PubMed Web of Science ®Google Scholar
• Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C, et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 39: 1166–71
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Cervera Segura R. Sjögren syndrome and hepatitis C virus: casual or etiopathogenic relationship. Rev Clin Esp 2001; 201: 515–7
   PubMedGoogle Scholar
• Verbaan H, Carlson J, Eriksson S, Larsson A, Liedholm R, Manthorpe R, et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients. J Intern Med 1999; 245: 127–32
   PubMed Web of Science ®Google Scholar
• Loustaud-Ratti V, Riche A, Liozon E, Labrousse F, Soria P, Rogez S, et al. Prevalence and characteristics of Sjögren's syndrome or sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol 2001; 28: 2245–51
   PubMedGoogle Scholar
• Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 2005; 38: 55–63
   PubMed Web of Science ®Google Scholar
• Sisto M, Lisi S, Lofrumento D, D'Amore M, Scagliusi P, Mitolo V. Autoantibodies from Sjögren's syndrome trigger apoptosis in salivary gland cell line. Ann NY Acad Sci 2007; 1108: 418–25
   PubMed Web of Science ®Google Scholar
• Ulbricht KU, Schmidt RE, Witte T. Antibodies against alpha-fodrin in Sjögren's syndrome. Autoimmun Rev 2003; 2: 109–13
   PubMed Web of Science ®Google Scholar
• Witte T, Matthias T, Oppermann M, Helmke K, Peter HH, Schmidt RE, et al. Prevalence of antibodies against alpha-fodrin in Sjögren's syndrome: comparison of 2 sets of classification criteria. J Rheumatol 2003; 30: 2157–9
   PubMedGoogle Scholar
• Nordmark G, Rorsman F, Ronnblom L, Cajander S, Taussig MJ, Kampe O, et al. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay. Clin Exp Rheumatol 2003; 21: 49–56
   PubMedGoogle Scholar
• Witte T, Matthias T, Bierwirth J, Schmidt RE. Antibodies against alpha-fodrin are associated with sicca syndrome in the general population. Ann NY Acad Sci 2007; 1108: 414–7
   PubMed Web of Science ®Google Scholar
• Ruffatti A, Ostuni P, Grypiotis P, Botsios C, Tonello M, Grava C, et al. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J Rheumatol 2004; 31: 504–7
   PubMedGoogle Scholar
• Sordet C, Gottenberg JE, Goetz J, Bengoufa D, Humbel RL, Mariette X, et al. Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome. Ann Rheum Dis 2005; 64: 1244–5
   PubMedGoogle Scholar
• Zandbelt MM, Vogelzangs J, Van De Putte LB, Van Venrooij WJ, Van Den Hoogen FH. Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome. Arthritis Res Ther 2004; 6: R33–8
   Google Scholar
• Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, et al. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus. J Rheumatol 2000; 27: 2617–20
   PubMed Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696–9
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929–38
   PubMed Web of Science ®Google Scholar
• Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978; 379: 103–12
   PubMed Web of Science ®Google Scholar
• Beuers U, Wiedmann KH, Kleber G, Fleig WE. Therapy of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis. Consensus of the German Society of Digestive System and Metabolic Diseases. Z Gastroenterol 1997; 35: 1041–9
   PubMedGoogle Scholar
• Nagao Y, Hanada S, Shishido S, Ide T, Kumashiro R, Ueno T, et al. Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection. J Gastroenterol Hepatol 2003; 18: 258–66
   PubMedGoogle Scholar
• Langegger C, Wenger M, Duftner C, Dejaco C, Baldissera I, Moncayo R, et al. Use of the European preliminary criteria, the Breiman-classification tree and the American-European criteria for diagnosis of primary Sjögren's syndrome in daily practice: a retrospective analysis. Rheumatol Int 2007; 27: 699–702
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996; 55: 116–21
   PubMed Web of Science ®Google Scholar
• Vitali C, Sciuto M, Neri R, Greco F, Mavridis AK, Tsioufas AG, et al. Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hyper-gamma-globulinaemia. Clin Exp Rheumatol 1992; 10: 103–4
   PubMed Web of Science ®Google Scholar
• Vidal E, Ranger S, Loustaud V, Verdier M, Liozon F, Denis F. Suspected multiviral involvement in primary Sjögren's syndrome. Clin Exp Rheumatol 1994; 12: 227
   PubMed Web of Science ®Google Scholar
• Mariette X, Zerbib M, Jaccard A, Schenmetzler C, Danon F, Clauvel JP. Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum 1993; 36: 280–1
   PubMedGoogle Scholar
• Marrone A, Di Bisceglie AM, Fox P. Absence of hepatitis C viral infection among patients with primary Sjögren's syndrome. J Hepatol 1995; 22: 599
   PubMed Web of Science ®Google Scholar
• Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169–73
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J. Is hepatitis C virus a sialotropic virus?. Am J Pathol 2001; 159: 1593–4
   PubMedGoogle Scholar
• Ramos-Casals M, Sanchez-Tapias JM, Pares A, Forns X, Brito-Zeron P, Nardi N, et al. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome. J Rheumatol 2006; 33: 1593–9
   PubMed Web of Science ®Google Scholar
• Routsias JG, Tzioufas AG. Sjögren's syndrome: study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 2007; 32: 238–51
   PubMed Web of Science ®Google Scholar
• Pellicano R, Smedile A, Peyre S, Astegiano M, Saracco G, Bonardi R, et al. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view. Minerva Gastroenterol Dietol 2005; 51: 55–61
   PubMedGoogle Scholar
• Wesche B, Jaeckel E, Trautwein C, Wedemeyer H, Falorni A, Frank H, et al. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut 2001; 48: 378–83
   PubMedGoogle Scholar
• Doffoel-Hantz V, Loustaud-Ratti V, Ramos-Casals M, Alain S, Bezanahary H, Liozon E, et al. Evolution of Sjögren syndrome associated with hepatitis C virus when chronic hepatitis C is treated by interferon or the association of interferon and ribavirin. Rev Med Interne 2005; 26: 88–94
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Garcia-Carrasco M, Brito Zeron MP, Cervera R, Font J. Viral etiopathogenesis of Sjögren's syndrome: role of the hepatitis C virus. Autoimmun Rev 2002; 1: 238–43
   PubMedGoogle Scholar
• Maruyama T, Saito I, Hayashi Y, Kompfner E, Fox RI, Burton DR, et al. Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity. Am J Pathol 2004; 165: 53–61
   PubMedGoogle Scholar